SLC3A1: Cystine, Dibasic and Neutral Amino Acid Transporter
Solute Carrier Family 3 Member 1 – Cystinuria and Amino Acid Transport
Gene Information Card
| Symbol | SLC3A1 |
|---|---|
| Full Name | Solute Carrier Family 3 Member 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 2p21 |
| NCBI Gene ID | 6519 ncbi.nlm.nih.gov/gene/6519 |
| Ensembl ID | ENSG00000138079 |
| UniProt ID | Q07837 |
| OMIM ID | 104614 |
| HGNC ID | 11025 |
| Aliases | rBAT, D2H, NBAT, ATR1 |
Description
SLC3A1 encodes the heavy subunit (rBAT) of the heteromeric amino acid transporter responsible for the reabsorption of cystine and dibasic amino acids in the renal proximal tubule and small intestine. The protein forms a functional complex with light subunits (e.g., SLC7A9) via a disulfide bond. Defects in SLC3A1 cause cystinuria type I, an autosomal recessive disorder characterized by defective renal transport of cystine, ornithine, lysine, and arginine, leading to recurrent cystine kidney stones.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cystinuria type I | Loss-of-function mutations in SLC3A1 impair the renal reabsorption of cystine and dibasic amino acids, leading to elevated urinary cystine and stone formation. | OMIM #220100; ClinVar; multiple case-control studies |
| Cystinuria (general) | Defective heteromeric amino acid transporter (rBAT/bo,+AT) results in hyperexcretion of cystine, ornithine, lysine, and arginine. | OMIM; NCBI GeneReviews |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Kidney | 12.5 | Medium |
| Small intestine | 8.3 | Medium |
| Liver | 2.1 | Low |
| Testis | 1.8 | Low |
| Pancreas | 1.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 15.2 | High expression in transfected models |
| Caco-2 | 9.8 | Intestinal epithelial cell line |
| HK-2 | 11.4 | Proximal tubule cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1500+1G>A | Splice donor | ~5% in European cystinuria patients | Loss of function |
| p.Met467Thr | Missense | ~3% in Mediterranean populations | Loss of function |
| p.Arg270Leu | Missense | ~2% in Asian cohorts | Loss of function |
| c.114delC | Frameshift | Rare | Loss of function |
Mutation functional classification
Loss of Function (LOF)
Most SLC3A1 mutations are loss-of-function, impairing transporter trafficking or activity, leading to cystinuria type I.
Gain of Function (GOF)
No gain-of-function mutations reported in SLC3A1.
Dominant Negative (DN)
No dominant-negative effects described; cystinuria type I is recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Amino acid transport across the plasma membrane (Reactome: R-HSA-352230)
• Transport of inorganic cations/anions and amino acids/oligopeptides (Reactome: R-HSA-425393)
• Cystinuria (KEGG: hsa05320)
Protein Summary
The SLC3A1 protein (rBAT) is a type II membrane glycoprotein of 685 amino acids. It serves as the heavy subunit of the heteromeric amino acid transporter bo,+AT (with SLC7A9). rBAT is essential for the trafficking and functional expression of the light subunit at the apical membrane of renal and intestinal epithelial cells. The protein contains a single transmembrane domain, a large extracellular domain with a VWFA-like fold, and multiple N-glycosylation sites. Mutations that disrupt folding, trafficking, or disulfide bonding with the light subunit lead to cystinuria.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC3A1 Knockout HEK293 Cell Line | EDJ-KQ5765 | Human | 6519 | Details Get a Quote |
| SLC3A1 Knockout A-549 Cell Line | EDJ-KQ29180 | Human | 6519 | Details Get a Quote |
| SLC3A1 Knockout HeLa Cell Line | EDJ-KQ54484 | Human | 6519 | Details Get a Quote |
| SLC3A1 Knockout HCT 116 Cell Line | EDJ-KQ71441 | Human | 6519 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records